相似文献
1
A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials.
Gut. 2004 May;53 Suppl 4(Suppl 4):iv58-65. doi: 10.1136/gut.2003.034371.
2
Cisapride treatment for gastro-oesophageal reflux in children.
Cochrane Database Syst Rev. 2003(4):CD002300. doi: 10.1002/14651858.CD002300.
3
Cisapride treatment for gastro-oesophageal reflux in children.
Cochrane Database Syst Rev. 2002(3):CD002300. doi: 10.1002/14651858.CD002300.
4
Cisapride treatment for gastro-oesophageal reflux in children.
Cochrane Database Syst Rev. 2000(3):CD002300. doi: 10.1002/14651858.CD002300.
5
Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease.
Cochrane Database Syst Rev. 2005 Apr 18(2):CD003245. doi: 10.1002/14651858.CD003245.pub2.
6
Systematic review: maintenance treatment of gastro-oesophageal reflux disease with proton pump inhibitors taken 'on-demand'.
Aliment Pharmacol Ther. 2007 Jul 15;26(2):195-204. doi: 10.1111/j.1365-2036.2007.03381.x.
7
Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
Cochrane Database Syst Rev. 2006 Jul 19(3):CD002095. doi: 10.1002/14651858.CD002095.pub3.
8
Acid reflux treatment for hoarseness.
Cochrane Database Syst Rev. 2006 Jan 25(1):CD005054. doi: 10.1002/14651858.CD005054.pub2.
9
Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
Cochrane Database Syst Rev. 2001(4):CD002095. doi: 10.1002/14651858.CD002095.
10
Medical treatments in the short term management of reflux oesophagitis.
Cochrane Database Syst Rev. 2007 Apr 18(2):CD003244. doi: 10.1002/14651858.CD003244.pub2.
引用本文的文献
1
Does the evidence show that prokinetic agents are effective in healing esophagitis and improving symptoms of GERD?
Open Med. 2007;1(3):e181-3. Epub 2007 Dec 4.
2
Meta-analysis: the effects of placebo treatment on gastro-oesophageal reflux disease.
Aliment Pharmacol Ther. 2010 Jul;32(1):29-42. doi: 10.1111/j.1365-2036.2010.04315.x. Epub 2010 Mar 26.
3
Validation of the PAGI-SYM and PAGI-QOL among healing and maintenance of erosive esophagitis clinical trial participants.
Qual Life Res. 2010 May;19(4):551-64. doi: 10.1007/s11136-010-9620-x. Epub 2010 Feb 27.
4
Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group.
Digestion. 2009;80(2):74-88. doi: 10.1159/000219365. Epub 2009 Jun 17.
本文引用的文献
1
Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results.
Aliment Pharmacol Ther. 2003 Feb;17(3):333-41. doi: 10.1046/j.1365-2036.2003.01464.x.
2
The new proton pump inhibitor esomeprazole is effective as a maintenance therapy in GERD patients with healed erosive oesophagitis: a 6-month, randomized, double-blind, placebo-controlled study of efficacy and safety.
Aliment Pharmacol Ther. 2001 Jul;15(7):927-35. doi: 10.1046/j.1365-2036.2001.01024.x.
3
Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial.
Am J Gastroenterol. 2001 Mar;96(3):656-65. doi: 10.1111/j.1572-0241.2001.3600_b.x.
4
Rabeprazole, 20 mg once daily or 10 mg twice daily, is equivalent to omeprazole, 20 mg once daily, in the healing of erosive gastrooesophageal reflux disease.
Scand J Gastroenterol. 2000 Dec;35(12):1245-50. doi: 10.1080/003655200453566.
5
Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety.
Am J Gastroenterol. 2001 Jan;96(1):27-34. doi: 10.1111/j.1572-0241.2001.03443.x.
6
Rabeprazole for the prevention of pathologic and symptomatic relapse of erosive or ulcerative gastroesophageal reflux disease. Rebeprazole Study Group.
Am J Gastroenterol. 2000 Nov;95(11):3081-8. doi: 10.1111/j.1572-0241.2000.03179.x.
7
Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial. Pantoprazole US GERD Study Group.
Am J Gastroenterol. 2000 Nov;95(11):3071-80. doi: 10.1111/j.1572-0241.2000.03254.x.
8
Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial. The Esomeprazole Study Investigators.
Aliment Pharmacol Ther. 2000 Oct;14(10):1249-58. doi: 10.1046/j.1365-2036.2000.00856.x.
9
Rabeprazole for the prevention of recurrent erosive or ulcerative gastro-oesophageal reflux disease. Rabeprazole Study Group.
Eur J Gastroenterol Hepatol. 2000 Aug;12(8):889-97. doi: 10.1097/00042737-200012080-00008.
10
Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: a double-blind, randomized clinical trial. Raberprazole Study Group.
Am J Gastroenterol. 2000 Aug;95(8):1894-9. doi: 10.1111/j.1572-0241.2000.02233.x.
Zotero 插件